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1. Introduction 
The results of numerous clinical studies confirm the presence of cardiac abnormalities in 
patients with rheumatoid arthritis. Their authors emphasize the utility of echocardiography 
in detecting heart muscle damage, pericardial involvement and valvular heart disease in 
RA. Bacon and Gibson, using one-dimentional imaging mode, found mitral valve changes in 
6.9% of their patients and ascribed it to the systemic spread of the disease.  Prakash, Nomeir 
and MacDonald noted mitral valve defects in 25, 30 and 10% of RA individuals, 
respectively. Using two-dimensional technique Mody discovered the same disorder in 13% 
of his RA cases and additionally aortic valve insufficiency in a small percentage of this 
subset. Toumanidis et al. revealed mitral valve and aortic cusps derangements in about 24% 
of their RA patients.  In Wisłowska’s study mitral valve insufficiency was present in 8.6% of 
RA patients and occurred more frequently in them than in the controls. One must take into 
consideration, however, that mitral valve prolaps is observed in up 18% of healthy 
individuals, and therefore can not be regarded an RA characteristic. 
Echocardiography also revealed discrepancies in heart muscle structure and function 
between RA patients and the control groups. Wisłowska found left ventricular mass in RA 
individuals significantly greater then in the controls. The same concerned intraventricular 
septum end diastolic thickness, LV posterior wall end diastolic thickness and the aortic root 
diameter. The ejection fraction was significantly lower and isovolumetric relaxation time 
(IVRT) and deceleration time significantly longer in RA patients compared to the controls. 
These findings are in accordance with Alpaslan, Di Franco and Levendoglu’s results, that 
revealed significant differences in LV diastolic function (peak E velocity, E velocity/A 
velocity ratio, IVRT, myocardial performance index [MPI] and transmural flow propagation 
velocity [TFPV]) between RA group and the control subjects. The results of these studies 
indicate to the presence of subclinical myocardial involvement in RA, which can be ascribed 
to nonspecific myocarditis observed in this disease. Nevertheless different other risk factors 
for cardiac muscle impairment are usually present in RA individuals and therefore it is 
uncertain, whether heart pathology in rheumatoid arthritis is due to inflammation itself or is 
secondary to other process or to drug use in this disease. 
Although pericardial effusion is considered the most common heart complication in RA, 
Wisłowska et al. observed it only on 4% of cases in echocardiography image. Pathologists 
find it in about 30% of RA cases post mortem, but clinical manifestation of pericarditis is 
rare in this disease. It’s life-threatening complications such as constrictive pericarditis or 
tamponade were reported in very few RA cases, to date. 
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Rheumatoid arthritis (RA) is a connective tissue disease predominantly affecting joints and 
periarticular structures. Inflammatory process within  the skeletal system  - a source of 
patients’ main complaints and eventual disability – draws the attention of medical service to 
the extent that sometimes results in negligence of  other aspects of the systemic disorder. 
These in turn can be of importance, since inflammation in RA, as in other connective tissue 
diseases is widespread and affects such vital tissues and organs as those of the 
cardiovascular system, for instance. Extraarticular manifestations in RA however develop 
slowly and are poorly manifested. Their symptoms tend to be are assigned rather to 
patient’s general malaise and the lack of fitness. Heart involvement is often asymptomatic or 
causes mild ailments, frequently disregarded by affected persons, because RA individuals 
are generally not energetic and avoid to move too much. Chest pain or fatigue in them 
happens to be contributed to skeletal system involvement rather then to other pathological 
process. These are perhaps the reasons why at least twice as many changes in RA hearts are 
recognized post-mortem then during the patient’s’ lifetime. One of the current issues in 
rheumatology therefore is to recognize the presence, type and the extend of heart 
involvement in RA and to search for correlations of their appearance and intensity with the 
disease clinical picture. Echocardiography appears to be of much help in this aspect. The 
development of this domain improved cardiological diagnostics, providing a valuable tool 
to assess the condition of heart structures and their functional properties. It enabled 
detecting even minor cardiac muscle, valvular and pericardial aberrations, also in 
asymptomatic individuals. Based on these observations numerous clinical studies to date 
focused on echocardiography application in RA and it’s utility in diagnosing cardiovascular 
complications of the disease. 
 
 
Fig. 1. Echocardiogram of RA patient LP female, age 46 - mitral valve prolaps 
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One of the firsts to examine echocardiography images RA patients were Bacon and Gibson 
[1]. In their one-dimentional examination of 44 individuals with classical or definite RA – 22 
with palpable rheumatoid nodules and 22 without them – they demonstrated the presence 
of pericardial effusion in 34% of patients. It was detected in 50% of those with nodular and 
in 18% of those with non-nodular disease course. In most cases the fluid did not cause 
symptoms of pericarditis, although in several patients it was 1-2 cm in depth. No correlation 
could be seen between the appearance of effusion and the disease duration and pericardial 
pathology was not detected in age-matched controls with noninflammatory osteoarticular 
pathology. Bacon and Gibson also found mitral valve changes in 6.9% of their RA patients. 
In their study the average mitral diastolic closure rate in the control group was 116 mm/s 
(range 75 to 180; normal range over 80 mm/s). It was significantly lower in nodular RA 
group (63 mm/s), then in the non–nodular one (p<0.05) and in the controls (p<0.001), and 
only in 5 nodular patients the values were normal. In 3 nodular patients they were markedly 
decreased (less then 30 mm/s), symptomatic for severe rheumatic stenosis. In non-nodular 
group mean mitral diastolic closure rate was 94 mm/s (range 40-200) and only in 4 cases the 
values were below normal range. The frequency of diminished rate of mitral valve 
movement in this study increased with age in RA individuals, but not in the controls and 
increased with RA duration. The recording of a diminished rate of spontaneous mitral valve 
movement during the mid-diastolic partial closure period was a new observation. The 
correlation of decreased mitral diastolic closure rate with the duration of the disease, it’s 
coincidence with severe nodular process and pericardial effusion was, according to authors, 
a strong argument for considering this parameter representative for a systemic RA 
manifestation.   
Other investigators in 70-ties (Prakash et al. [2], Nomeir et al. [3] and MacDonald et al. [4]) 
reported mitral valve derangements in 25, 30 and 10% of RA patients, respectively. Prakash 
et al. [2] performed a prospective echocardiography study to search for cardiac 
abnormalities in 1 female and 15 male American patients (11 white and 5 black persons), 
free of cardiac symptoms. 44% of them had evidence of posterior pericardial effusion, not 
detected by electrocardiogram nor by the chest X-ray study. The E to F slope of the anterior 
leaflet of mitral valve was reduced in  25% of patients, which according to authors, could be 
due either to rheumatoid involvement of the mitral valve cusps or to changes in left 
ventricular compliance, both common in people with long-standing rheumatoid arthritis. 
The study revealed high prevalence of mitral valve and pericardial involvement in RA 
patients, previously only found in post-mortem studies and confirmed the utility of 
echocardiography in RA diagnosis.  
In 1973 Nomeir et al. [3] studied the nature and extent of cardiac involvement in RA 
patients. Physical examination of 30 Americans with classic RA did not show any significant 
cardiac abnormalities, while echocardiography revealed pericardial effusion in 46.6% and 
mitral valve defects in 30% of patients, therefore demonstrating the presence of one of these 
pathologies in quite a large number of RA individuals. Although there was no correlation 
between different modalities of the study, echocardiography was claimed by the authors the 
most sensitive method of detecting cardiac complications of RA at early disease stage.  
In 1975 in turn, Davia et al. [5] examined 35 consecutive American RA patients, submitting 
them to echocardiography to evaluate the motion of the anterior mitral valve leaflet. In 
contrast to previous results, through analysis they revealed normal valve motion and a 
normal E/F slope in as many as 31 of them. The authors discovered, that falsely low E/F 
slope values were noted only when  the technique applied was not sufficiency meticulous, 
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while the improvement of method resulted in normalization of these values. Their 
conclusion therefore was that anterior mitral valve leaflet abnormalities rarely if ever are 
seen in RA patients, provided that careful attention to recording technique is observed. 
 
 
Fig. 2. Echocardiogram of RA patient AM female, age 58 - pericardial effusion 
The results obtained by Nomeir et al. [6] in their subsequent study initially showed that 18 
out of 30 their RA patients had cardiac involvement arising from the disease at baseline of 
the examination [3]. Abnormalities detected by echocardiography comprised mitral valve 
disease or pericardial alterations, or both.  All patients were then followed up for 4 years 
from the initial workup. At the end of the study mitral valve abnormalities were still seen in 
63% of those in whom they were previously present and pericardial effusion remained in 
20%. Pericardial thickening persisted in 6 out of 7 patients. There was no definitive 
correlation between the protraction of these abnormalities and other clinical data, but it was 
noticed that patients who retained pericardial effusion and mitral valve abnormalities 
showed a higher number of joints involved and a higher erythrocyte sedimentation rate. It is 
worth mention that none of the patients developed constrictive pericarditis nor the heart 
failure and that all abnormalities detected remained clinically insignificant. The results of 
the study suggest that an impressive number of RA patients suffer from cardiac 
abnormalities related to their disease which may be clinically undetectable and are rarely 
life- threatening or requiring surgery support.  
MacDonald et al. [4] performed clinical, electrocardiographic (ECG) and echocardiography 
examinations in 51 American outpatients with RA. 31% of patients had echocardiographic 
evidence of pericardial effusion and in 2 patients pericardial thickening was demonstrated. 
Mitral valve E/F slope was normal in as many as 46 out of 51 persons and left ventricular 
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performance was depressed only in a few cases. The authors concluded that in unselected 
outpatients with RA pericardial abnormalities detected by echocardiograph are common 
although usually clinically unapparent. 
Toumanidis et al. [8] visualized mitral and aortic cusps changes in about 24% of their 
patients. 
In the Hungarian study of Nagyhegyi et al. [9] 100 of patients suffering from ankylosing 
spondylitis (AS) and 100 patients with RA were examined by clinical, non-invasive 
cardiological, radiological and laboratory methods to determine the prevalence of cardiac 
and cardiopulmonary disorders. 14 patients with AS and 24 with RA had several valvular 
abnormalities. Among those without valvular defects, myocardial systolic dysfunction was 
detectable in 15 AS and 11 RA cases and cor pulmonale was diagnosed in 16 and 7 patients, 
respectively. Conduction disturbances were demonstrated in 17 AS and 14 RA individuals. 
Mody et al. [7]  from South Africa examined their Negro-Caucasoids patients with RA seen 
in the rheumatic diseases unit during a 16-months period preceding the study. The authors 
aimed at determining the prevalence of cardiac abnormalities in RA. They used random 
tablets to select a group out of 330 persons and finally 101 of RA individuals underwent 
clinical and echocardiography examination. Adequate two-dimentional assessments were 
obtained in 84 patients and adequate M-mode recordings in 77. 31patients (37%) had 45 
echocardiographic abnormalities, in 5 patients (6%) pericardial effusion was detected. 11 
abnormalities of mitral valve noted in 10 (13%) patients: 3 had mitral valve prolaps, 1 - aortic 
incompetence and flutter on the mitral valve, in 5 patients mitral annular calcium was 
detected and 1  patient had hypertrophic obstructive cardiomyopathy and mitral calcium 
deposits. The reduction in E/F slope was noted in 12 patients, 7 of whom had associated 
cardiac disease, 1 patient had sinus tachycardia and 4 (5%) - a mild reduction of E/F slope 
without any other cardiac abnormality. The authors concluded that apart from the presence 
of pericardial effusion in 6% and minor abnormalities of the E/F slope in 5% of patients, all 
other significant echocardiographic abnormalities could be related to the presence of 
associated cardiac disease.    
In 1983 Villecco et al. [10] from Italy confirmed the utility of echocardiography in detection 
of cardiac lesions in RA patients. In order to verify the frequency and the extend of heart 
pathology, the authors performed mechanophonocardiographic studies and simultaneous 
mono- and bi-dimentional echocardiography in 28 RA individuals. They showed an increase 
in the PEP/LVET ratio on the polycardiogram in 1 case and echocardiographic alterations in 
18 (64.3%) of patients. Pericardial effusion was noted in 21.4%, the thickening of 
pericardium in 14.3%, alterations of mitral valve (the reduction in  protodiastolic closing 
velocity of the anterior edge of the large mitral valve) in 35.7% and thickening of the 
interventricular septum in 17.9% of cases. The authors reckoned all measurements results to 
be good indicators of cardiac complications in RA. According to them such examinations 
allow to identify a group of patients suffering from abnormalities otherwise undetectable.  
Wisłowska et al. [11,12] in Poland observed higher frequency of valvular heart disease, 
especially mitral insufficiency in RA patients than in the control group. Echocardiographic 
examinations were carried out in 100 patients (age<65 years) with rheumatoid arthritis 
(stages II–IV according to Steinbrocker’s criteria). The control group consisted of 100 
patients with osteoarthrosis, spondyloarthrosis and painful shoulder matched for age, sex 
and body surface area (BSA). All patients with myocardial infarction, hypertension, 
rheumatic fever or a history of diabetes were excluded from the study. Echocardiographic 
examination revealed more cases of valvular heart disease, especially mitral insufficiency, in 
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RA patients then in the control group.  Mitral valve prolaps was noted in 6% of RA 
individuals and pericardial effusion in 4%, whereas it was absent in the control group and in 
all patients during of clinical assessment prior to echocardiography imaging. In all 4% the 
volume of fluid was less then 300 ml, which was considered neglectable. Patients with RA 
had greater diastolic left ventricular diameter and aortic root diameter, as well as a smaller 
ejection fraction, mean velocity of cimcumferential fibre shortening and fractional 
shortening than the control individuals. The comparison of results of the echocardiographic 
measurements on different RA stages or in relation to the functional index, seropositivity 
and seronegativity and in person of different disease duration did not reveal any statistically 
significant discrepancies. In 39% of RA patients and 19% of the controls valvular heart 
disease was discovered by echocardiographic examination (p<0.05). Mitral valve 
insufficiency (I and II degree) was noted in 29% of RA patients and in 10% of the controls 
(p<0.005), aortic insufficiency (I and II degree) in 8 RA patients and 4 of the control group 
(NS), tricuspid insufficiency in 3 RA individuals and in 2 control subjects (NS) and mitral 
stenosis in 1 RA patient. In total, valvular heart disease was seen in  47 RA cases and in 19 
control subjects. Only in 4% of cases pericardial effusion was detected, though this 
abnormality is considered the most common heart complication in RA.  
There is much controversy in literature, regarding the frequency of mitral valve prolaps in 
general population, where it fluctuated from 3–8% up to 18% in different clinical studies 
[13,14], as well as in RA patients [6]. In Wisłowska’s nodular group the prevalence of this 
abnormality was 8.6% [12]. Such discrepancies make impossible to classify it as an RA 
characteristics. 
In another study Wisłowska et al. [12] compared the results echocardiographic 
examinations in 35 patients with nodular and 35 with non–nodular RA. The groups were 
matched for age, sex and the BSA. 35 patients with osteoarthrosis and spondyloarthrosis 
matched with both RA groups formed a control group. Patients with history of 
myocardial infarction, hypertension, rheumatic fever and diabetes were excluded from 
the study. Echo-Doppler cardiography and echocardiographic Holter monitoring revealed 
cardiac involvement in 71.9% of patients with nodular RA and 42.9% of non–nodular 
cases compared to 22.9% of the control group (p<0.0002). Echocardiographic examination 
revealed more cases of valvular heart abnormalities, especially mitral insufficiency, in 
nodular RA patients than in non-nodular and the controls. Both mitral valve prolaps and 
pericardial effusion were noted in 8.6% of nodular subjects. Patients with nodular RA also 
had greater aortic root diameter, a smaller ejection fraction, and smaller mean velocity of 
circumferential fiber shortening and fractional shortening compared to ones non-nodular 
and to the control group subjects.     
In another study concerning systolic and diastolic heart function in RA patients Wisłowska 
et al. [15] found left ventricular (LV) mass index in RA significantly greater than in the 
control group. The same concerned intraventricular septum end-diastolic thickness, LV 
posterior wall end-diastolic thickness and the aortic root diameter. The ejection fraction in 
RA patients was significantly lower than in the control group. The assessment of diastolic 
function parameters revealed significantly longer isovolumetric relaxation time and 
deceleration time in RA patients. 
Similar results were presented by Alpaslan et al. [16], Di Franco et al. [17], and Levendoglu 
et al. [18]. In their studies echocardiographic indices of LV diastolic function (peak E 
velocity, E velocity/A velocity ratio, isovolumetric relaxation time [IVRT], myocardial 
performance index [MPI] and transmural flow propagation velocity [TFPV]) in RA group 
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were significantly different from those of the controls. The reported finding indicate to the 
presence of subclinical myocardial involvement in RA, which is most probably due to the 
nonspecific myocarditis observed in these patients. Such myocardial involvement was 
elsewhere described as asymptomatic, rarely influencing cardiac size or function, 
predominantly affecting LV diastole, usually of diffuse pattern and scarcely clinically 
significant. It is not know to date, however, to what extent cardiac pathology in RA emerge 
from inflammatory myocarditis itself or is secondary to other pathology or drug use in this 
disease.  
 
 
Fig. 3. Echocardiogram of RA patient BS female, age 50 - aortic valve insufficiency 
Toumanidis et al. [8]  examined a Greek population to evaluate early morphological and 
functional heart abnormalities. The examined group was free of risk factors for coronary 
artery disease and without any clinically evident cardiac manifestations. Echocardiography 
examination  was performed in 62 patients with collagen disease, 15 with rheumatoid 
arthritis and in 40 healthy individuals. The imager was taken from apical four-chamber view 
at rest and during the end of a 3- minute isometric exercise with handgrip. Global and 
regional ejection fraction (EF) of  left ventricle were calculated. In the RA group the EF was 
62.38±6.88% vs 61.47±8.52% in the controls. Regional EF analysis revealed a major 
dysfunction of the proximal segment of interventricular septum in all groups and reduced 
separation of mitral and aortic valve leaflets in RA. 
In Maione et al. [19] echocardiography examination of consecutive 39 Italian RA and 40 
control subjects the occurrence of anatomic lesions was lower then that observed in other 
studies. No differences in mean values of left and right ventricular diastolic function indices 
obtained by Doppler echocardiography were found between patients and the controls. 
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However, in 26% of patients with RA, left ventricular abnormalities, probably secondary to 
myocardial fibrosis were detected. Pericardial effusions (less than 300 ml) were found in 3 
RA patients (7%) and in none of the controls. Pericardial adhesion was seen in 1 RA patient 
only. Valvular involvement (1 case of mitral stenosis and 1 case of aortic stenosis) was 
detected in 2 RA cases, both having had suffered from rheumatic heart disease in  the past. 
Moreover, the prevalence both: minor changes of mitral valve and trivial regurgitation was 
similar in the investigated groups. Left atrial or left ventricular dilation was found in  5 RA 
patients out of whom 3 were affected by coronary artery disease and 2 by valvular disease 
and in none of the control subjects. Left ventricular hypertrophy was present in 2 RA 
patients, both suffering from essential hypertension and in none of the controls. EF was 
normal in all except 3 RA patients, all of whom with ECG evidence of previous myocardial 
infarction. To investigate diastolic heart function the observers  excluded persons with 
arterial hypertension, diabetes and valvular heart disease (4 RA cases and 1 from the control 
group). To further exclude the presence of occult heart disease patients and the controls 
underwent an echo-dobutamine provocative test. Afterwards echocardiographic indices of 
LV and RV diastolic function were calculated in 35 RA and 39 control subjects. The authors 
found no statistically significant differences in mean values of the parameters examined. 
Nevertheless diastolic function abnormalities consisting of IVRT prolongation and inverted 
E/A ratio were pointed out in 9 out of 35 (26%) RA cases and in 2 out of 39 (5%) controls. 
The difference was statistically significant (Fisher exact test, p=0.019) and considered  due to 
the decrease in peak early diastolic velocity of the mitral valve. An inverted E/A ratio of the 
tricuspid flow velocity profile was detected in 3 RA patients, all with LV filling 
abnormalities, and was not detected in the controls.       
Di Franco et al. [17] studied an Italian population to evaluate the LV filling parameters by 
the analysis of transmitral flow and pulmonary venous flow with special regard to patients’ 
age and the disease duration. 32 RA cases without evidence of concomitant cardiac disease 
were selected and compared to matched control subjects. All patients and the control group 
were submitted to M-mode, two-dimensional Doppler and color Doppler (continuous and 
pulsed wave) echocardiography. Diastolic parameters evaluated comprised  transmitral 
flow (E/A ratio), pulmonary venous flow (S/D ratio), a-Pw, IVRT and deceleration time 
(DT). In RA LV filling disturbances were apparent and characterized by a reduced E/A ratio 
(mean SD 1.16 [0.31] vs 1.37 [0.32] in the controls) (p= 0.02) and increased S/D ratio (1.43 
[0.40] vs 1.22 [0.29] in the controls) (p=0.017). In this group of patients the correlation 
between E/A ratio and the disease duration (r=0.40, p=0.01 Spearman rank correlation) was 
also noted. The authors concluded that RA patients, in absence of overt heart disease, show 
diastolic function characterized by impaired E/A and S/D ratio. According to them it’s 
relation to the disease duration suggests the presence of subclinical myocardial 
involvement. 
In another Italian study Corrao et al. [20] investigated and verified diastolic abnormalities in 
rheumatoid patients, without clinically evident cardiovascular disease and other 
confounding complaints, by using pulsed Doppler examination of transmitral blood flow. 
They selected 40 patients fulfilling revised American Rheumatism Association (ARA) 
criteria for the diagnosis of rheumatoid arthritis with no symptoms of cardiac disease, nor 
clinical findings of other extracardiac pathology, matched with 40 healthy volunteers as a 
control. An echocardiographic examination was carried out in each subject. LV structural 
and functional measurements were obtained. Intraventricular septum thickness and LV 
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mass index were significantly higher in rheumatoid patients than in the control. RA patients 
had higher mean values of peak A velocity and A/E ratio. When multiple linear regression 
data analysis was performed, an independent relationship only between A/E ratio and LV 
mass was found. The results confirmed the presence of diastolic abnormalities in 
rheumatoid patients and pointed out that these abnormalities also affect echo-Doppler 
parameters of LV filling. The study results further suggest that structural LV changes can be 
responsible for LV filling impairment. 
One more Italian study was carried out by Montecucco et al. [21] who used digitized M-
mode and Doppler echocardiography to assess LV function in 54 patients (mean age 50 
years) suffering from active RA, without obvious cardiovascular disease. The group was 
compared with 54 age and sex matched normal subjects. No differences were found in LV 
end-diastolic diameter, systolic function and parietal thickness between patients and the 
controls. However, a significant reduction of various indices of LV diastolic function was 
recorded, including E/A ratio and the peak lengthening rate of the LV diameter (an index of 
relaxation evaluated by M-mode echocardiography). The former was correlated with 
patients’ age and was independent of disease duration while the latter was more markedly 
correlated with the disease duration then with the patients’ age. The authors suggested that 
the observation of relationship between diastolic impairment and the disease duration in 
active RA may open new perspectives for the study of RA-associated cardiovascular disease. 
Voipio-Pulkki and Saraste [22] examined a Finish RA population. LV function was studied 
in 182 outpatients with rheumatoid arthritis compared with 182 controls matched for age 
and sex. Patients with RA showed mild but definite tachycardia and lower systolic and 
diastolic blood pressures at rest. PEP/LVET was equal in both groups and LV mass assessed 
by echocardiography tended to be increased in males with seropositive disease, while no 
differences were found in ejection fractions. Mean velocity of cimcumferential fibre 
shortening (VCF) was significantly higher in female patients then in the controls. As VCF 
corrected for heart rate showed no difference between patients and controls, this apparently 
reflected an adequate response to the higher pulse rate. Taken together, the results do not 
support the concept of LV dysfunction in chronic RA, but rather an altered haemodynamic 
state caused by the disease itself or by it’s treatment. 
The next Finish study performed by Mustonen et al. [23] concerned cardiac  performance in 
12 asymptomatic male patients with RA and 14 control subjects. It was planed to elucidate 
early disturbances in cardiac function in these subsets. In echocardiography, an IVRT and 
peak filling rate lower in RA patients then in the controls, which apparently reflected an  
impairment in LV diastolic function. LV diastolic function assessed by radionuclide 
angiocardiography at rest and during exercise was similar in both groups. There were no 
differences between the patients and the control subjects, as regards the heart rate, systolic 
blood pressure and oxygen uptake during peak exercise. LV diastolic function was impaired 
in spite of normal LV systolic function in RA patients without clinically evident 
cardiovascular disease and the authors suggested that the excess of cardiovascular mortality 
in RA patients can be ascribed to this phenomenon. They emphasized the importance of 
further epidemiological studies to elucidate this matter. 
Kozakova et al. [24] performed echocardiographic, electrocardiographic and roentgenologic 
examinations in 50 Czech patients with RA and no clinical signs of pericardial effusion. 
Using one-dimentional echocardiography, pericardial effusion was detected in 27 (54%) 
subjects. Neither valvular involvement nor specific changes in myocardium were found. In 
sera of patients with pericardial effusion the presence of rheumatoid factor was significantly 
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more frequent then in patients without effusion. Patients on steroid therapy for the primary 
disease had statistically lower incidence of pericardial involvement than patients who were 
subjected to other forms of treatment. Again, echocardiography proved to be the only 
sensitive non-invasive method capable of detecting small and medium-sized effusions in 
pericardial cavity. 
In the next Czech echocardiography study of Alusik and Skalicka [25] pericardial effusion 
was detected in 35 out of 104 RA patients. The amount of fluid was small in 29, medium in 3 
and large in 3 of them. The thickening of pericardium was seen in 4 patients, mitral valve 
prolaps in 22 and thickened mitral valve in 10. In  24 patients the authors found a small 
regurgitation at the mitral valve in 10 patients it was more significant. Thickened aortic 
valve was seen in 14, a small regurgitation though the valve in 8 and a significant one in 4 
patients. The LV dilatation was detected in 13 subjects, it’s hypertrophy in 12 and an 
impaired kinetics in another 12 individuals. Dilatation of the RV was seen in 15 and it’s 
hypertrophy in 3 patients. Ventricular hypertrophy and dilatation as well as an impaired LV 
were interpreted as consequences of valvular involvement and of associated diseases.     
Alpaslan et al. [16] examined a Turkish population of RA patients to assess ventricular 
function by measurement of myocardial performance index (MPI) and transmitral flow 
propagation velocity (TFPV), which they reckoned better indices of ventricular function 
than hithero utilized pulsed-Doppler echocardiography of LV inflow, the results of which 
were affected by changes in pre- and afterload, tachycardia or first degree A-V block as well 
as pseudonormalisation phenomenon. 32 patients with long-standing RA and 32 control 
subjects participated in the study. Systolic function was assessed by subjective evaluation of 
wall motion for both ventricles and by the assessment of fractional shortening of the LV. LV 
diastolic function was evaluated by standard pulsed-wave Doppler echocardiography, the 
MPI and the TFPV. RV function was evaluated by MPI. No subject has signs nor symptoms 
of clinically overt heart failure. Systolic function was normal in all of them. 
Echocardiographic functional indices of LV diastolic performance: the peak E velocity, E/A 
velocity ratio, IVRT, MPI and TFPV in the RA group were significantly different from those 
of the controls (p<0.05). However, the authors did not observe any significant difference in 
RV echocardiographic indices between the two groups. Their results show, the presence of 
LV diastolic dysfunction in patients with long-standing RA. The lack of history of 
cardiotoxic antirheumatic drug use suggested that this abnormality was due to RA itself. 
The study showed that LV MPI and TFPV, both easily obtained and not affected by 
ventricular geometry, well identify the presence of LV diastolic dysfunction in patients with 
long-standing disease. The findings were in accordance with the results of classic 
measurements methods of LV function: decreased E/A ratio and prolonged IVRT.  
Levendoglu et al. [18] in the study on Turkey population tried to evaluate cardiac 
involvement in patients with active rheumatoid arthritis. 40 of them participated in the 
study. All were submitted to standard Doppler echocardiography and MPI grading, which 
revealed LV and RV diastolic function abnormalities with LV MPI significantly higher than 
in controls (p<0.05). A relationship was also found between LV E/A ratio, IVRT and the 
disease duration (r=-0.47 and p=0.002, r=0.618 and p=0.000, respectively). Diastolic function 
was impaired in both ventricles and a direct relationship between some of the parameters of 
LV diastolic function and the disease duration was observed, too. The findings suggest the 
presence of subclinical myocardial involvement in RA patients. The earliest deterioration in 
cardiac disease is an impaired diastolic function. Such abnormalities have been reported in a 
number of conditions such as arterial hypertension, coronary artery disease and in elderly 
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subjects, yet the authors selected patients without no evidence of heart problems and 
impaired ventricular function was observed at all ages in RA, contrary to the control group. 
Another Turkish study performed by Arslan et al. [26] was planned to evaluate LV diastolic 
function in patients with active RA by the analysis of conventional Doppler and tissue 
Doppler echocardiographic imaging (TDI). 52 patients with active RA and 47 healthy 
persons were included in this study. All were evaluated by M-mode, two-dimentional 
conventional Doppler echocardiography and the TDI. Late diastolic flow velocity (A) and 
deceleration time (DT) values were higher in patients with RA than that in the control group 
(p<0.001) and E/A ratio was lower in RA than in the controls (p<0.001). Among TDI 
parameters mitral annular early diastolic velocity (Em) and Em/Am (mitral annular late 
diastolic velocity) ratio were lower in  RA patients then in the control group (p<0.001). The 
correlation was found between A (r=0.43, p=0.001), DT (r=0.30, p=0.03), E/A ratio (r=0.409, 
p =0.004), Em (r=0.32, p=0.02), Em/Am ratio (r=0.30, p=0.03) and E/Em (r=0.32, p=0.02) and 
the RA duration. The authors concluded, that patients with active RA in absence of clinically 
evident heart disease show diastolic dysfunction characterized by impaired E/A ratio, 
Em/Am ratio and the DT. The relation between diastolic dysfunction and the disease 
duration suggests a subclinical myocardial involvement. 
The Turkish study of Rexhepaj et al. [27] was aimed the assessment of prevalence of 
diastolic LV and RV dysfunction in patients with rheumatoid arthritis. The authors tried to 
estimate whether there is a correlation between the duration of RA and the degree of LV 
diastolic failure. 81 patients (61 females and 20 males) with RA and without clinically 
evident heart disease (group 1) and 40 healthy subjects (29 females and 11 males) (group 2) 
were matched for age and sex. Echocardiographic and Doppler studies revealed significant 
differences in E, A and E/A ratio (0.68±0.19 m/s vs. 0.84±0.14 m/s, p<0.001; 0.73±0.15 m/s 
vs. 0.66±0.13 m/s, p=0.01; and 0.97±0.3 vs. 1.32±0.37, p<0.001, respectively) between RA 
patients and the controls. Significant difference between groups was also noted in RV early 
diastolic (Er)/atrial (Ar) flow velocities (Er/Ar ratio) (1.07±0.3 vs. 1.26±0.3, p=0.002) and 
weak correlation was observed between transmitral E/A ratio and the duration of RA 
(r=−0.22, p=0.001). The MPI appeared to differ little in patients with RA as compared to the 
control group (0.51±0.1 vs. 0.52±0.2, p=NS). In RA individuals without clinically evident 
cardiovascular disease the LV and RV diastolic function were reduced. LV wall thickness, 
it’s dimensions, systolic function and the MPI remained normal.  
Another Turkish investigators Yazici et al. [28] suggested that RA is associated with 
increased risk of cardiovascular mortality. Considering that  cardiovascular findings are 
mostly subtle and diastolic function abnormalities are one of the earliest manifestations, 
they aimed at determining diastolic abnormalities in RA at baseline and after a 5-year 
follow-up. 72 RA patients without any known cardiac disease and 67 controls were recruited 
for the study. Disease activity score (DAS), blood lipids and C-reactive protein (CRP) levels 
were determined. LV mass, IVRT, E and A were determined by M-mode two-dimensional 
color Doppler echocardiography. Mitral annular early (E’) and late (A’) diastolic velocities 
were also checked by TDI. 24 RA patients were reevaluated after 5 years for DAS, 
biochemical variables and echocardiography. In 57 out of 72 (76%) of them and in 12 of the 
67 (18%) controls diastolic dysfunction (DD) was diagnosed. In 7 out of 10 patients with DD 
at baseline it remained in the follow-up, while in 8 patients normal diastolic function 
sustained. DAS and lipid values did not altered during the follow-up and CRP levels 
decreased significantly (p<0.05). In conclusion, RA patients are prone to develop diastolic 
function abnormalities in comparison to healthy controls. A 5-year follow-up of this group 
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showed that although clinical response was unsatisfactory, cardiac function was conserved 
without a major deterioration. Moreover, disease-modifying antirheumatic drugs 
(DMARDs), such as anti-TNF alpha agent, did not seem to have a major adverse effect on 
cardiac findings in patients. 
The Turkish study of Birdane et al. [29] was aimed at the comparison of standard Doppler 
and TDI results in RA patients. In 60 such individuals with longstanding disease LV and RV 
parameters were assessed by standard pulsed-wave Doppler echocardiography, the color 
M-mode flow propagation velocity and the TDI. LV TDI was achieved at 4 different sites 
(lateral, septal, anterior and inferior walls) and RV TDI - through the tricuspid lateral 
annulus. The analysis of the results showed that the basal clinical and echocardiographic 
parameters: E, A, diastolic velocities of atrioventricular valves, E/A ratio and pulmonary 
venous Doppler parameters were similar in both groups. The values of LV and RV 
E/wave deceleration times and IVRT of RA patients were greater then in healthy controls 
(p<0.05). RA patients also had significantly lower color M-mode flow propagation 
velocity (p<0.05), while S′ peak and E′ peak, two of the LV and RV parameters were 
similar in both groups.  Furthermore A′ peak, E′/A′, and E/E′ values showed statistically 
significant differences among RA patients. The results confirmed the presence of LV and 
RV impairment in RA. 
In another Turkish study Seyfeli et al. [30] investigated RV diastolic function in RA and it’s 
relationship with LV function and pulmonary involvement. 35 RA patients and 30 healthy 
controls were submitted to conventional Doppler (CE) and tissue Doppler 
echocardiography (TDE) to assess LV and RV systolic and diastolic function and to estimate 
maximal arterial systolic pulmonary pressure (PAP). To detect pulmonary involvement, 
pulmonary function tests and high-resolution computed tomography (HRCT) scans were 
performed in all RA individuals. An abnormal RV filling, as expressed by an inverted 
tricuspid (Tr.) E/A ratio, was detected in 12 (34%) of RA patients and in 2 (7%) of controls 
(p<0.004). The prevalence of RV diastolic abnormalities was higher in RA patients examined 
by TDE, than by CE (RV annulus Em/Am ratio <1 in 31 (89%) of patients) (p=0.002). 22 
(63%) RA subjects had abnormal HRCT findings. Pulmonary involvement with pulmonary 
hypertension (PHT) (36±5 mmHg) was detected in 10 (29%). In this group an increased RV 
annulus and basal Am wave, decreased Tr. E/A ratio and the decreased RV annulus 
Em/Am ratio were statistically significant compared to RA patients with pulmonary 
involvement, who had normal PAP (19±5 mmHg: 12 [34%] of 35), p=0.014, p=0.006, p=0.015, 
p=0.049, respectively). The study revealed an impaired RV filling in a significant part of RA 
patients without overt heart failure. Impairment of RV diastolic function can be a predictor 
of subclinical myocardial and pulmonary involvement in RA. 
The aim of the next Turkish study of Guyler et al. [31] was the assessment of P wave 
dispersion (PWD) as a sign for the prediction of atrial fibrillation (AF) and it’s relation to 
clinical and echocardiographic parameters in RA patients. 30 patients (mean age 49±10 
years) and 27 healthy controls (mean age 47±8 years) were included in the study and 
electrocardiography and Doppler echocardiography was performed. Maximum and 
minimum P wave duration were obtained from electrocardiographic measurements. PWD 
defined as the difference between maximum and minimum P wave duration was calculated. 
Maximum P wave duration and PWD were higher in RA patients than in the controls 
(p=0.031 and p=0.001, respectively), however there were no significant correlation between 
PWD and disease duration (r=0.375, p=0.009) and IVRT (r=0.390, p=0.006). P wave duration 
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and PWD was higher in RA patients than in the controls and was closely associated with the 
disease duration and LV diastolic dysfunction. 
In the last Turkish study Canturk et al. [32] evaluated diastolic functions in patients with RA 
by assessment of propagation velocity and intraventricular dispersion of E wave velocity. 34 
RA cases without evidence of cardiac disease and LV systolic impairment were enrolled in 
the study. Echocardiographic examinations were performed for the evaluation of diastolic 
dysfunction (DD) in all of them. Propagation velocity in RA patients was significantly lower 
than in the control group (42±16 cm/s, 54±15 cm/s, p=0.002). There was significant 
intraventricular dispersion of E wave velocity towards the cardiac apex in RA patients 
(p<0.001) compared to the controls (p=0.79). There was also a significant correlation 
between intraventricular dispersion of E wave velocity and diastolic dysfunction in the 
patients in which the duration of illness was longer than 10 years (p<0.001). The authors 
concluded that an impaired LV relaxation in RA, correlated with the duration of the disease 
might be due to structural myocardial abnormalities. Furthermore, the combined use of 
propagation velocity and intraventricular E wave dispersion measurements can help in 
early determination of diastolic functions in RA patients. 
The Russian publication of Krasnosel'skĭ et al. [33] concerned the use of tissue 
dopplerography (TDG) in detection of myocardial involvement in  RA by assessment of the 
velocity of myocardial movement. TDG was carried out in 22 patients with verified RA (age 
33-66, mean age 45.2±7.4 years) and in 20 healthy volunteers (age 29-58, mean age 44.6±8.4 
years). Modules of velocities of systolic and early diastolic peaks in LV wall at basal level 
and at levels of upper, middle and lower thirds were calculated in all patients. In some LV 
segments the results correlated with CRP and ESR in RA (r from 0.29 to 0.46) and were 
diffusely lowered in this disease, which on author’s opinion reflected the participation of 
inflammatory process in development of asymptomatic diffuse myocardial damage in RA. 
Gonzales-Juanatey et al. [34] examined Spanish population towards the frequency of 
echocardiographic and Doppler abnormalities in long-term treated RA patients without 
clinically overt heart disease. 47 such individuals, treated for at least 5 years with 1 or more 
DMARDs were recruited. Those with cardiovascular risk factors, cardiovascular or 
cerebrovascular events were excluded from the study. 47 healthy persons formed the control 
grouping patients with RA. The presence of aortic regurgitation (17%) and tricuspid 
regurgitation (17%) was higher than in the controls (15% and 6%, respectively). Pulmonary 
artery systolic pressure was higher in RA patients (30.3±8.0 mmHg) compared to the in 
control subjects (26.2±4.8) (p=0.004). The incidence of pulmonary artery systolic pressure 
above 35 mm Hg was significantly higher in RA patients (21% versus 4% in controls;  
p= 0.03), diastolic dysfunction caused by impaired relaxation was more common in patients 
with RA (66%) than in controls (43%) (p=0.02) and more frequent in older patients. 
Extraarticular manifestations were more common in patients with RA in whom diastolic 
dysfunction was recognized (p=0.05). This study confirmed a high frequency of LV diastolic 
dysfunction and pulmonary hypertension in patients with RA without evident 
cardiovascular disease. 
In French patients Meune et al. [35] were determined the sensitivity and accuracy of tissue-
Doppler echocardiography (TDE) to assess myocardial contractility. The stimulus of this 
study was an observation that heart failure was one of the determinants of the excess 
mortality in RA patients. Consecutive 27 RA individuals with normal results of cardiac 
clinical examination were prospectively included and compared to 27 controls. All 
underwent conventional echocardiography, furthermore their systolic and diastolic strain 
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rate (SR) were determined by TDE. When compared to the controls RA patients had 
increased LV mass (99±24 vs 80±25g/m2, p=0.009), and a trend towards left atrial 
enlargement (31±3 vs 29±6 mm, p=0.006). Fractional shortening and systolic SR did not 
differ between groups. Diastolic function, as estimated by the E/A Doppler velocity ratio 
was similar in both populations (p=0.18). However, diastolic SR was strikingly reduced in 
patients with RA versus controls (3.7±1.3 vs 5.5±1.1 s-1, p <0.001). In 18 out of 27 RA patients 
markedly reduced diastolic SR (SR<4s-1) was noted, too. None of the RA characteristics was 
associated with significant differences in TDE measurements. This study confirmed that 
TDE enable to identify impaired diastolic function in RA even in cases where it can not be 
detected by conventional measurements.    
An Indian project of Uddayakumar et al. [36] was one of the in numerous studies on the 
prevalence of diastolic dysfunction in RA from Indian subcontinent. The aim of it was to 
evaluate LV filling abnormalities in RA patients without clinically evident cardiovascular 
manifestations and to search for their correlation with the disease duration. 45 such patients 
affected by RA diagnosed according to ARA criteria were selected and compared with age 
and sex matched control subjects. All were submitted to M-mode, two-dimensional and 
Doppler echocardiography. E, A, E/A ratio, IVRT, EF and fractional shortening were 
evaluated. In RA patients LV filling abnormalities were characterized by a reduced E/A 
ratio (mean [SD] 0.98 [0.22]) compared to the controls (1.09 [0.11]; p-value equals 0.004), 
prolonged IVRT (75.77 [8.12] ms versus 70.43 [2.94] ms; p-value equals 0.001) and increased 
late diastole flow velocity (76.91 [11.61] cm/s versus 70.11 [5.32] cm/s; p-value equals 0.001). 
A negative correlation was found between E/A ratio and the disease duration (Pearson 
correlation, r equals -0.56, p-value equals 0.001), indicating that diastolic dysfunction rate 
increased with disease duration. A strong correlation was also found between IVRT and the 
disease duration (r equals 0.66, p-value equals 0.01) and between late diastolic flow velocity 
and the disease duration (r equals 0.61, p-value equals 0.001). The study confirms a high 
frequency of LV diastolic dysfunction characterized by impaired E/A ratio, prolonged IVRT 
and increased late diastole flow velocity in patients with RA without evident cardiovascular 
disease. The correlation between transmitral flow alteration and the disease duration 
suggests a progressive subclinical myocardial involvement with the disease progression. 
This may be relevant to high incidence of cardiovascular deaths observed in patients with 
RA. 
Honda et al. [37] from Japan performed in 1981 studied cardiac function and vascular 
hemodynamics by non–invasive means in order to assess LV performance in 50 RA patients 
and 30 healthy controls. They did not find significant difference in LV end-diastolic 
dimension, LV posterior wall thickness, LV posterior wall excursion and mean posterior 
wall velocity between groups, yet the ejection fraction and ejection time/preejection period 
were significantly decreased.  Hemodynamic status in patients with advanced RA in this 
study was characterized by mild tachycardia and a mild decrease of LV function, pericardial 
effusion was also noted in these individuals. 
Echocardiography, a rapidly developing diagnostic procedure enable to examine heart 
structure and function in different clinical setting. It can be particularly useful  in connective 
tissue diseases, such as rheumatoid arthritis. Generalized inflammatory process in these 
conditions affects heart muscle directly and through changes in tissue vasculature induced 
by cytokins and other inflammatory mediators of prothrombotic and atherogenic properties. 
Inflammatory vasculitis, another well-known complication of RA, especially of long 
duration, also contribute to heart damage in this disease. Cardiac muscle fibrosis and 
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amyloidosis, that develop as further sequels of rheumatoid arthritis, add to cardiovascular 
system, especially diastolic function, impairment. Thrombus formation at heart valves with 
consecutive stenosis and/or regurgitations is an independent factor that disturb heart 
function in RA individuals. 
Furthermore, one must not neglect the deleterious effects of drugs used to combat RA on 
cardiopulmonary system. Non-steroid anti-inflammatory agents with their water-retention 
and renal-toxic effects can induce or exacerbate hypertension and heart failure. So can cause 
corticosteroids, yet these are also known to strongly enhance atherogenesis and thrombosis. 
Methotrexate, the most popular and most effective of conventionally used DMARDs is able 
to induce lung fibrosis and therefore cause pulmonary hypertension, moreover it is renal-
toxic. Chloroquine exerts proarrhytmic effect and cyklosporin induce hypertension. Gold 
salts, as well as D-penicillamine are also known to be capable of causing vasculitis and 
adversely affect patients’ cardiovascular risk factor profile. 
All these data clearly indicate to high risk of cardiovascular diseases in RA patients. 
Echocardiography in turn enables to detect early pathological changes of this kind and 
therefore can be helpful in prevention of the development of life-threatening complications. 
The results of studies presented in this topic confirm the utility of different 
echocardiography techniques in detecting heart damage in RA patients. Echocardiography 
visualizes for example decreased LV diastolic performance, as the earliest predictor of 
development of left ventricular heart failure, different kinds of valvular defects, pulmonary 
hypertension and the presence of pericardial effusion. The last one, although rarely 
clinically significant and only scarcely causing life-threatening complications is tamponade 
or constrictive pericarditis. Pericarditis is nevertheless present in about 30% of RA cases 
post-mortem [38]. It’s appearance during patient’s diagnostics could therefore be useful in 
recording cardiovascular involvement by RA, difficult or impossible to visualize by 
conventional methods. Another echocardiography application in RA is to investigate 
correlations between heart changes and the disease duration and activity, as well as with the 
patient’s age. The discovery of such dependences can be helpful in prediction and therefore 
prevention of heart damage and perhaps other complications of RA. 
Taken together – echocardiography is a chance for improving diagnostic methods in RA, yet 
further investigations are needed to work out techniques and medical standards in such 
patients. Hagendorff and Pfeiffer [39] focused on echocardiography application in modern 
diagnostics of connective tissue diseases, with special regard for rheumatoid arthritis. The 
authors concluded, that the prerequisites for successful diagnostic echocardiography in RA 
are the knowledge of modern echocardiographic techniques like tissue Doppler and contrast 
echocardiography and clinical experience with patients with rheumatoid arthritis. The 
standardization of procedures is important for reproducibility and comparability of  results. 
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